CAS 1374248-77-7: Ubrogepant

Description: Ubrogepant is a small molecule medication primarily used for the acute treatment of migraine attacks in adults. It belongs to a class of drugs known as CGRP (calcitonin gene-related peptide) receptor antagonists, which work by blocking the action of CGRP, a neuropeptide involved in the pathophysiology of migraines. Ubrogepant is characterized by its oral bioavailability and relatively rapid onset of action, making it effective for migraine relief. Its chemical structure includes specific functional groups that contribute to its pharmacological activity and selectivity for the CGRP receptor. The substance is typically administered in tablet form and is known for its favorable safety profile, with a lower incidence of side effects compared to traditional migraine treatments. Ubrogepant's development represents a significant advancement in migraine management, providing an alternative for patients who may not respond well to other therapies. As with any medication, it is essential for users to consult healthcare professionals for appropriate usage and potential interactions with other drugs.

Formula: C₂₉H₂₆F₃N₅O₃

InChI: InChI=1S/C29H26F3N5O3/c1-16-20(17-6-3-2-4-7-17)11-22(26(39)37(16)15-29(30,31)32)35-25(38)19-10-18-12-28(13-23(18)34-14-19)21-8-5-9-33-24(21)36-27(28)40/h2-10,14,16,20,22H,11-13,15H2,1H3,(H,35,38)(H,33,36,40)/t16-,20-,22+,28+/m1/s1

InChI key: InChIKey=DDOOFTLHJSMHLN-ZQHRPCGSSA-N

SMILES: O=C(NC1C(=O)N(CC(F)(F)F)C(C)C(C=2C=CC=CC2)C1)C3=CN=C4C(=C3)CC5(C(=O)NC6=NC=CC=C65)C4

Synonyms:

• Ubrelvy
• Ubrogepant
• Spiro[6H-cyclopenta[b]pyridine-6,3′-[3H]pyrrolo[2,3-b]pyridine]-3-carboxamide, 1′,2′,5,7-tetrahydro-N-[(3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)-3-piperidinyl]-2′-oxo-, (3′S)-
• (3′S)-1′,2′,5,7-Tetrahydro-N-[(3S,5S,6R)-6-methyl-2-oxo-5-phenyl-1-(2,2,2-trifluoroethyl)-3-piperidinyl]-2′-oxospiro[6H-cyclopenta[b]pyridine-6,3′-[3H]pyrrolo[2,3-b]pyridine]-3-carboxamide
• MK 1602

Ubrogepant-d5

CAS: 1374248-77-7

• Formula: C₂₉H₂₁D₅F₃N₅O₃
• Molecular weight: 554.58

Ubrogepant

CAS: 1374248-77-7

• Formula: C₂₉H₂₆F₃N₅O₃
• Molecular weight: 549.55

Ubrogepant

CAS: 1374248-77-7

• Purity: 99.79%
• Molecular weight: 549.54g/mol

Ubrogepant

CAS: 1374248-77-7

Please enquire for more information about Ubrogepant including the price, delivery time and more detailed …

• Formula: C₂₉H₂₆F₃N₅O₃
• Purity: Min. 95%
• Molecular weight: 549.54 g/mol

Ubrogepant

CAS: 1374248-77-7

Ubrogepant (MK-1602) is an antagonist of calcitonin gene-related peptide receptor that can be used in …

• Formula: C₂₉H₂₆F₃N₅O₃
• Purity: 99.79%
• Color and Shape: Solid
• Molecular weight: 549.54